![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: BRD1 |
Gene summary for BRD1 |
![]() |
Gene information | Species | Human | Gene symbol | BRD1 | Gene ID | 23774 |
Gene name | bromodomain containing 1 | |
Gene Alias | BRL | |
Cytomap | 22q13.33 | |
Gene Type | protein-coding | GO ID | GO:0002262 | UniProtAcc | A0A024R4V5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23774 | BRD1 | male-WTA | Human | Thyroid | PTC | 2.99e-21 | 1.33e-01 | 0.1037 |
23774 | BRD1 | PTC01 | Human | Thyroid | PTC | 4.45e-02 | -9.52e-03 | 0.1899 |
23774 | BRD1 | PTC04 | Human | Thyroid | PTC | 3.18e-11 | 2.53e-01 | 0.1927 |
23774 | BRD1 | PTC05 | Human | Thyroid | PTC | 2.19e-17 | 4.10e-01 | 0.2065 |
23774 | BRD1 | PTC06 | Human | Thyroid | PTC | 6.35e-30 | 5.92e-01 | 0.2057 |
23774 | BRD1 | PTC07 | Human | Thyroid | PTC | 1.64e-34 | 5.20e-01 | 0.2044 |
23774 | BRD1 | ATC12 | Human | Thyroid | ATC | 4.76e-07 | 7.78e-02 | 0.34 |
23774 | BRD1 | ATC13 | Human | Thyroid | ATC | 6.09e-32 | 5.61e-01 | 0.34 |
23774 | BRD1 | ATC2 | Human | Thyroid | ATC | 9.16e-11 | 7.10e-01 | 0.34 |
23774 | BRD1 | ATC3 | Human | Thyroid | ATC | 2.31e-02 | 1.49e-01 | 0.338 |
23774 | BRD1 | ATC4 | Human | Thyroid | ATC | 2.41e-08 | 1.25e-01 | 0.34 |
23774 | BRD1 | ATC5 | Human | Thyroid | ATC | 4.92e-34 | 6.17e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001003814 | Breast | IDC | response to metal ion | 65/1434 | 373/18723 | 2.95e-10 | 3.42e-08 | 65 |
GO:005507613 | Breast | IDC | transition metal ion homeostasis | 23/1434 | 138/18723 | 3.20e-04 | 4.79e-03 | 23 |
GO:004691612 | Breast | IDC | cellular transition metal ion homeostasis | 20/1434 | 115/18723 | 4.35e-04 | 5.90e-03 | 20 |
GO:0010039 | Breast | IDC | response to iron ion | 8/1434 | 32/18723 | 2.32e-03 | 2.10e-02 | 8 |
GO:000682611 | Breast | IDC | iron ion transport | 11/1434 | 58/18723 | 4.10e-03 | 3.25e-02 | 11 |
GO:005507212 | Breast | IDC | iron ion homeostasis | 14/1434 | 85/18723 | 4.98e-03 | 3.77e-02 | 14 |
GO:001003824 | Breast | DCIS | response to metal ion | 65/1390 | 373/18723 | 8.03e-11 | 9.88e-09 | 65 |
GO:005507622 | Breast | DCIS | transition metal ion homeostasis | 23/1390 | 138/18723 | 2.04e-04 | 3.27e-03 | 23 |
GO:004691621 | Breast | DCIS | cellular transition metal ion homeostasis | 20/1390 | 115/18723 | 2.91e-04 | 4.27e-03 | 20 |
GO:00100391 | Breast | DCIS | response to iron ion | 8/1390 | 32/18723 | 1.90e-03 | 1.81e-02 | 8 |
GO:000682621 | Breast | DCIS | iron ion transport | 11/1390 | 58/18723 | 3.23e-03 | 2.73e-02 | 11 |
GO:005507221 | Breast | DCIS | iron ion homeostasis | 14/1390 | 85/18723 | 3.78e-03 | 3.03e-02 | 14 |
GO:0043112 | Colorectum | AD | receptor metabolic process | 62/3918 | 166/18723 | 8.18e-07 | 2.85e-05 | 62 |
GO:0072583 | Colorectum | AD | clathrin-dependent endocytosis | 24/3918 | 47/18723 | 4.60e-06 | 1.22e-04 | 24 |
GO:0006898 | Colorectum | AD | receptor-mediated endocytosis | 76/3918 | 244/18723 | 1.07e-04 | 1.59e-03 | 76 |
GO:0072665 | Colorectum | AD | protein localization to vacuole | 27/3918 | 67/18723 | 2.40e-04 | 3.04e-03 | 27 |
GO:0061462 | Colorectum | AD | protein localization to lysosome | 19/3918 | 46/18723 | 1.36e-03 | 1.19e-02 | 19 |
GO:0007369 | Colorectum | AD | gastrulation | 53/3918 | 185/18723 | 7.60e-03 | 4.60e-02 | 53 |
GO:0031623 | Colorectum | AD | receptor internalization | 35/3918 | 113/18723 | 7.72e-03 | 4.66e-02 | 35 |
GO:00431121 | Colorectum | MSS | receptor metabolic process | 57/3467 | 166/18723 | 8.47e-07 | 2.97e-05 | 57 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
BRD1 | SNV | Missense_Mutation | novel | c.748N>C | p.Tyr250His | p.Y250H | O95696 | protein_coding | deleterious(0.02) | benign(0.429) | TCGA-B7-5816-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
BRD1 | SNV | Missense_Mutation | c.775N>T | p.Arg259Cys | p.R259C | O95696 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BR-4201-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | cisplatin | SD | |
BRD1 | SNV | Missense_Mutation | novel | c.3212A>G | p.Tyr1071Cys | p.Y1071C | O95696 | protein_coding | deleterious(0) | probably_damaging(0.946) | TCGA-BR-4362-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
BRD1 | SNV | Missense_Mutation | c.1397T>C | p.Ile466Thr | p.I466T | O95696 | protein_coding | deleterious(0) | benign(0.22) | TCGA-BR-4362-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
BRD1 | SNV | Missense_Mutation | c.350T>G | p.Leu117Arg | p.L117R | O95696 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BR-7707-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
BRD1 | SNV | Missense_Mutation | c.3226G>A | p.Ala1076Thr | p.A1076T | O95696 | protein_coding | deleterious(0) | benign(0.381) | TCGA-BR-8078-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
BRD1 | SNV | Missense_Mutation | c.2317N>A | p.Glu773Lys | p.E773K | O95696 | protein_coding | tolerated(0.23) | benign(0.011) | TCGA-BR-8382-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
BRD1 | SNV | Missense_Mutation | c.500N>T | p.Glu167Val | p.E167V | O95696 | protein_coding | deleterious(0) | possibly_damaging(0.73) | TCGA-BR-8487-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
BRD1 | SNV | Missense_Mutation | c.1265N>A | p.Ser422Tyr | p.S422Y | O95696 | protein_coding | deleterious(0.01) | possibly_damaging(0.904) | TCGA-BR-A4CS-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
BRD1 | SNV | Missense_Mutation | c.439N>A | p.Ala147Thr | p.A147T | O95696 | protein_coding | tolerated(0.3) | benign(0.167) | TCGA-CD-A4MI-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
23774 | BRD1 | ENZYME | inhibitor | 252166774 | ||
23774 | BRD1 | ENZYME | inhibitor | 336446910 |
Page: 1 |